Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Ca2+-stimulated adenylyl cyclases as therapeutic targets for psychiatric and neurodevelopmental disorders

Frontiers in Pharmacology(2022)10.3389/fphar.2022.949384Source: DataRank Database

Ca2+-stimulated adenylyl cyclases as therapeutic targets for psychiatric and neurodevelopmental disorders is a research paper published in Frontiers in Pharmacology (2022). On theSindex it has a DataRank of 0. It has been cited 17 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access17 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (5 grants)OA: goldTopics (13)IDs (PubMed, PMC)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (4)

Qi Ding ORCID,Lulu An,Hongbing Wang ORCID,Jiao Chen ORCID

Live enrichment

PubMed:36188604 PMC:PMC9523369

National Institute of Mental Health

Grant: R01MH124992 R01MH119149

NIMH NIH HHS

Grant: R01 MH124992

NIMH NIH HHS

Grant: R01 MH119149

National Institutes of Health

Grant: 1R01MH119149-01

Nonconventional role of ADCY in Gq-mediated neuronal signaling and neuroplasticity

National Institutes of Health

Grant: 5R01MH124992-04

Mechanism underlying cognitive and synaptic flexibility

goldLicense: cc-by

publisherhttps://www.frontiersin.org/articles/10.3389/fphar.2022.949384/pdf

publisherhttps://www.frontiersin.org/articles/10.3389/fphar.2022.949384/full

repositoryhttps://doaj.org/article/da9cd9c6fc9e416880fd6ecec4de7f7d

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/9523369

Europe_PMChttps://europepmc.org/articles/PMC9523369

Fields of Study

0301 basic medicine0303 health sciences03 medical and health sciences

Keywords

SchizophreniaTherapeuticsBipolar disorderAutismPost-traumatic Stress DisorderMajor Depressive DisorderCa2+-Stimulated Adenylyl CyclasePharmacologyTherapeutics. PharmacologyRM1-950

Sustainable Development Goals

SDG 3: 3. Good health